The pace of innovation in the scientific community has never stopped, especially in the field of biomedical science, where exciting new discoveries are made almost every day.
Biomedical research is expected to experience explosive growth in multiple fields by September 2025. The team of the Chinese Academy of Sciences has developed a new tumor immunotherapy strategy to create artificial targets on the surface of cancer cells through proximity labeling technology, significantly improving the efficiency of immune cell recognition and attack.
Stanford University researchers have successfully reversed autism like symptoms in mice and identified potential therapeutic targets. At the same time, Chongqing Medical University has collaborated with a European team to develop the efficient sequence alignment software LexicMap, which can quickly and accurately locate target sequences in millions of microbial genomes.
01 New Breakthrough in Tumor Immunotherapy: Adjacent Marker Technology Transforms into a Therapeutic Weapon
Han Shuo, the research team of the Center for Excellence and Innovation in Molecular Cell Science of the Chinese Academy of Sciences, made a major breakthrough by transforming the proximity marker technology originally used for basic research into an effective therapeutic tool.
The core of this technology is the development of an engineered nanoenzyme that can create artificial targets on the surface of tumor cells under deep red light or ultrasound excitation.
Researchers have introduced a specially designed T cell conjugator BiTE, which can simultaneously capture the antigen "patch" of cancer cells and immune T cells. This high-density marking is like sounding a battle signal, which can efficiently gather and activate the relevant recognition receptors on the surface of T cells, triggering the "strongest attack mode".
In animal experiments, this method can improve the striking effect by tens or even hundreds of times. After the nanoenzyme is stimulated, a decrease in tumor indicators can be observed one to two days later.
02 Research progress on autism and epilepsy: Overexcitation of the thalamic reticular nucleus becomes a key finding
A study by Stanford University has revealed the underlying neural mechanisms of autism, suggesting that excessive excitation of the thalamic reticular nucleus (RT) may be the driving force behind autistic behavior.
The research team successfully reversed autism like symptoms in a mouse model by using Z944 drug and DREADD technology, and demonstrated that this overexcitement is associated with epilepsy comorbidity.
This discovery is of great significance as it not only reveals the neural mechanisms of autism, but also identifies the comorbidity between autism and epilepsy. However, researchers emphasize that this study still needs to undergo rigorous human clinical trials to validate its effectiveness and safety.
03 Microbial genomics tool innovation: LexicMap achieves efficient sequence alignment
Associate Researcher Shen Wei from the Institute of Viral Hepatitis at the Second Affiliated Hospital of Chongqing Medical University collaborated with Professor Zamin Iqbal from the European Bioinformatics Institute (EMBL-EBI) to develop a new sequence alignment software, LexicMap.
This software supports accurate, fast, and low memory base level sequence alignment of genes, plasmids, and long read sequencing data in millions of prokaryotic (bacterial and archaeal) genomes.
Compared with existing methods, LexicMap is faster, consumes less memory, and has higher scalability while maintaining considerable accuracy. For example, in a database containing 2.34 million bacteria and archaea, comparing one gene and returning all matching results only takes 3 to 33 minutes.
This tool will enable researchers to achieve accurate and rapid sequence alignment of all sequenced microbial genomes globally in a single machine environment, providing strong support for research in epidemiology, ecology, evolutionary biology, and other fields.
04 Inflammatory mechanism of cardiovascular disease: synergistic effect of cholesterol and inflammation
Anum Saeed, assistant professor of the University of Pittsburgh Medical Center, pointed out that "inflammation is a clear risk factor for the progression of atherosclerosis and is directly related to myocardial infarction, ischemic stroke and ischemic heart failure."
Research has found gender differences in inflammatory biomarkers, which may lead to missed diagnosis of cardiovascular disease in women. In terms of clinical management, although statins can reduce LDL cholesterol and inflammatory burden, patients still have residual cardiovascular risks.
New therapies such as colchicine can significantly reduce the risk of acute coronary events, cardiac arrest, and other conditions. The phase II trial of IL-6 inhibitor ziltivekimab showed significant anti-inflammatory effects on high-risk populations such as chronic kidney disease.
05 Nanopore RNA sequencing technology: WarpDemuX enhances sample multiplex analysis capability
Researchers have launched WarpDemuX, an ultra fast and high-precision adapter barcode and demultiplexing method suitable for direct RNA sequencing of nanopores using SQK-RNA002 and SQK-RNA004 chemical methods.
This method improves speed and accuracy by quickly processing raw nanopore signals, using lightweight machine learning algorithms, and designing optimized barcode sets.
The research team conducted rapid phenotype analysis of different SARS-CoV-2 viruses by performing multiple sequencing on longitudinal samples in a flow pool, and identified systematic differences in transcript abundance and poly (A) tail length during infection.
06 Neutrophil Extracellular Traps: New Discoveries on Biomechanics Regulation Mechanisms
Research has found that mechanical signals such as shear stress, matrix hardness, and cyclic tensile critically regulate NET formation.
Neutrophil extracellular traps (NETs) are a double-edged sword: while essential for infection control and wound healing, excessive NETosis can drive chronic inflammation and tissue damage.
More and more evidence links the dysregulation of NET formation with cardiovascular disease and thrombotic events. Mechanical signals and cellular stress as effective non infectious triggering factors for NETosis have expanded our understanding beyond classical pathogen-driven activation。
These advances have placed NETs at the intersection of host defense and disease, sparking new interest in their therapeutic targets.
07 Single Cell SERS Analysis: A New Technology for Decoding Cell Heterogeneity
Single cell surface enhanced Raman scattering (SERS) has become a powerful tool for precision medicine, thanks to its label free detection, ultra sensitivity, and unique molecular fingerprint recognition capabilities.
Unlike traditional batch analysis, it can provide a detailed description of cell heterogeneity, especially in the identification of circulating tumor cells (CTCs), tumor microenvironment (TME) metabolism analysis, subcellular imaging, and drug sensitivity assessment, which have special prospects.
Despite obstacles in the safety, complex spectral interpretation, and clinical translation of nanoprobes, advances in AI driven data processing (such as convolutional neural networks) and miniaturized devices are accelerating towards intraoperative guidance, improved liquid biopsy, and primary healthcare applications.
This technology not only directly kills tumor cells, but also liberates new antigens and promotes epitope expansion - the immune system extends its recognition ability to multiple tumor epitopes, including distant untreated lesions.
Even if new cancer cells appear in the future, the immune system can immediately recognize and eliminate them, just like being vaccinated against tumors. This means that we may be moving towards a new era that not only treats cancer, but also provides long-term protection.
Future biomedical research will continue to develop towards personalization and precision, and the integration and innovation of multiple technologies will become the core driving force for advancing the field.
